Literature DB >> 33622951

Implementation of medicines pricing policies in sub-Saharan Africa: protocol for a systematic review.

Tolib Mirzoev1, Augustina Koduah2, Anna Cronin de Chavez3, Leonard Baatiema4, Anthony Danso-Appiah4, Tim Ensor3, Irene Akua Agyepong5, Judy M Wright6, Irene A Kretchy2, Natalie King6.   

Abstract

INTRODUCTION: Ensuring universal availability and accessibility of medicines and supplies is critical for national health systems to equitably address population health needs. In sub-Saharan Africa (SSA), this is a recognised priority with multiple medicines pricing policies enacted. However, medicine prices have remained high, continue to rise and constrain their accessibility. In this systematic review, we aim to identify and analyse experiences of implementation of medicines pricing policies in SSA. Our ambition is for this evidence to contribute to improved implementation of medicines pricing policies in SSA. METHODS AND ANALYSIS: We will search: Medline, Web of Science, Scopus, Global Health, Embase, Cairn.Info International Edition, Erudit and African Index Medicus, the grey literature and reference from related publications. The searches will be limited to literature published from the year 2000 onwards that is, since the start of the Millennium Development Goals.Published peer-reviewed studies of implementation of medicines pricing policies in SSA will be eligible for inclusion. Broader policy analyses and documented experiences of implementation of other health policies will be excluded. The team will collaboratively screen titles and abstracts, then two reviewers will independently screen full texts, extract data and assess quality of the included studies. Disagreements will be resolved by discussion or a third reviewer. Data will be extracted on approaches used for policy implementation, actors involved, evidence used in decision making and key contextual influences on policy implementation. A narrative approach will be used to synthesise the data. Reporting will be informed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols guideline. ETHICS AND DISSEMINATION: No ethics approvals are required for systematic reviews.Results will be disseminated through academic publications, policy briefs and presentations to national policymakers in Ghana and mode widely across countries in SSA. PROSPERO REGISTRATION NUMBER: CRD42020178166. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  health policy; international health services; public health

Year:  2021        PMID: 33622951      PMCID: PMC7907884          DOI: 10.1136/bmjopen-2020-044293

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  10 in total

1.  Differences in external price referencing in Europe: a descriptive overview.

Authors:  Christine Leopold; Sabine Vogler; A K Mantel-Teeuwisse; Kees de Joncheere; H G M Leufkens; Richard Laing
Journal:  Health Policy       Date:  2011-10-19       Impact factor: 2.980

Review 2.  Reforming the health sector in developing countries: the central role of policy analysis.

Authors:  G Walt; L Gilson
Journal:  Health Policy Plan       Date:  1994-12       Impact factor: 3.344

Review 3.  How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.

Authors:  Sabine Vogler; Valérie Paris; Alessandra Ferrario; Veronika J Wirtz; Kees de Joncheere; Peter Schneider; Hanne Bak Pedersen; Guillaume Dedet; Zaheer-Ud-Din Babar
Journal:  Appl Health Econ Health Policy       Date:  2017-06       Impact factor: 2.561

4.  Policy interventions related to medicines: Survey of measures taken in European countries during 2010-2015.

Authors:  Sabine Vogler; Nina Zimmermann; Kees de Joncheere
Journal:  Health Policy       Date:  2016-09-20       Impact factor: 2.980

Review 5.  Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries.

Authors:  Tuan Anh Nguyen; Rosemary Knight; Elizabeth Ellen Roughead; Geoffrey Brooks; Andrea Mant
Journal:  Health Policy Plan       Date:  2014-01-13       Impact factor: 3.344

Review 6.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

7.  All roads lead to universal health coverage.

Authors:  Tedros Adhanom Ghebreyesus
Journal:  Lancet Glob Health       Date:  2017-07-17       Impact factor: 26.763

8.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

Authors:  Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  BMJ       Date:  2015-01-02

9.  Medicines and universal health coverage: challenges and opportunities.

Authors:  Maryam Bigdeli; Richard Laing; Göran Tomson; Zaheer-Ud-Din Babar
Journal:  J Pharm Policy Pract       Date:  2015-02-16

10.  Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis.

Authors:  R Moodley; F Suleman
Journal:  BMC Health Serv Res       Date:  2019-08-16       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.